Article Versions Notes

Califano G, Ouzaid I, Laine-Caroff P, Peyrottes A, Collà Ruvolo C, Pradère B, Elalouf V, Misrai V, Hermieu J-F, Shariat SF, et al. Current Advances in Immune Checkpoint Inhibition and Clinical Genomics in Upper Tract Urothelial Carcinoma: State of the Art. Current Oncology. 2022; 29(2):687-697. https://doi.org/10.3390/curroncol29020060

Califano, Gianluigi, Idir Ouzaid, Paul Laine-Caroff, Arthur Peyrottes, Claudia Collà Ruvolo, Benjamin Pradère, Vincent Elalouf, Vincent Misrai, Jean-François Hermieu, Shahrokh F. Shariat, and et al. 2022. "Current Advances in Immune Checkpoint Inhibition and Clinical Genomics in Upper Tract Urothelial Carcinoma: State of the Art" Current Oncology 29, no. 2: 687-697. https://doi.org/10.3390/curroncol29020060

Califano, G., Ouzaid, I., Laine-Caroff, P., Peyrottes, A., Collà Ruvolo, C., Pradère, B., Elalouf, V., Misrai, V., Hermieu, J. -F., Shariat, S. F., & Xylinas, E. (2022). Current Advances in Immune Checkpoint Inhibition and Clinical Genomics in Upper Tract Urothelial Carcinoma: State of the Art. Current Oncology, 29(2), 687-697. https://doi.org/10.3390/curroncol29020060